Business & Industry
J&J Buys Halda for $3bn to Own the Cell Death Platform
Johnson & Johnson will be paying $3.05 billion so as to acquire Halda Therapeutics, thereby getting a novel cell death platform while at the same time also strengthening its prostate cancer franchise that’s built on Erleada.
At the mainstay of the...
BioPharma
CRISPR and Gene Editing: Next-Gen Manufacturing Impacts
The pharmaceutical and biotechnology industries are experiencing a profound technological revolution driven by CRISPR-Cas9 and emerging gene editing technologies that fundamentally alter how therapeutic agents are developed and manufactured. Gene editing pharma manufacturing represents far more than incremental improvement...
BioPharma
In Silico and Virtual Trials: Revolutionizing Drug Development
Drug development is entering an era of radical transformation as pharmaceutical companies embrace virtual trials and in silico methodologies to reimagine the clinical research process. These digital-first strategies tap into computational models, artificial intelligence, and patient-specific simulations to address...
BioPharma
Injectable Drug Delivery System Innovations
Innovations in Injectable and Parenteral Drug Delivery Systems
The evolution of injectable drug delivery systems marks a transformative period in pharmaceutical therapeutics, where technological sophistication converges with patient-centered design to revolutionize how medications reach their targets. Global market valuations exceeding...
BioPharma
Novel Excipients for Next Generation Drug Formulation
Exploring Novel Excipients for Next Generation Drug Formulation
The landscape of pharmaceutical development finds itself at a critical juncture where the complexity of drug molecules increasingly outpaces the capabilities of traditional formulation approaches. Novel excipients drug formulation represents not merely...
BioPharma
Advances in Lipid-Based Drug Formulations for Solubility
Advances in Lipid-Based Drug Formulation for Solubility Enhancement
The pharmaceutical industry faces a persistent challenge that threatens to derail promising drug candidates before they reach patients. Poor aqueous solubility afflicts over 70% of new molecular entities in development pipelines, creating...
BioPharma
Nanotechnology Transforming Oral Drug Delivery
Revolutionizing Oral Drug Delivery with Nanotechnology
The pharmaceutical landscape stands at a transformative juncture where nanotechnology oral drug delivery systems are reshaping how medications reach their therapeutic targets. This convergence of nanoscience and pharmaceutical formulation addresses fundamental challenges that have...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















